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Abstract
Background: The global distribution map of schistosomiasis shows a large overlap of Schistosoma haematobium- and S.
mansoni-endemic areas in Africa. Yet, little is known about the consequences of mixed Schistosoma infections for the
human host. A recent study in two neighboring co-endemic communities in Senegal indicated that infection intensities of
both species were higher in mixed than in single infections. Here, we investigated the relationship between mixed
Schistosoma infections and morbidity in the same population. So far, this has only been studied in children.
Methods: Schistosoma infection was assessed by microscopy. Schistosoma-specific morbidity was assessed by ultrasound
according to WHO guidelines. Multivariable logistic regression models were used to identify independent risk factors for
morbidity.
Principal Findings: Complete parasitological and morbidity data were obtained from 403 individuals. Schistosoma
haematobium-specific bladder morbidity was observed in 83% and S. mansoni-specific hepatic fibrosis in 27% of the
participants. Bladder morbidity was positively associated with S. haematobium infection intensity (OR= 1.9 (95% CI 1.3–2.9)
for a 10-fold increase in intensity). Moreover, people with mixed infections tended to have less bladder morbidity than those
with single S. haematobium infections (OR= 0.3 (95% CI 0.1–1.1)). This effect appeared to be related to ectopic S. mansoni
egg elimination in urine. Hepatic fibrosis on the other hand was not related to S. mansoni infection intensity (OR = 0.9 (95%
CI 0.6–1.3)), nor to mixed infections (OR= 1.0 (95% CI 0.7–1.7)).
Conclusions/Significance: This is the first population-wide study on the relationship between mixed Schistosoma infections
and morbidity. Mixed infections did not increase the risk of S. mansoni-associated morbidity. They even tended to reduce
the risk of S. haematobium-associated morbidity, suggesting a protective effect of S. mansoni infection on bladder
morbidity. These unexpected results may have important consequences for schistosomiasis control in co-endemic areas and
warrant further investigation.
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Introduction
Worldwide more than 207 million people are infected with
Schistosoma, 85% of whom live in Africa [1]. Due to the large overlap
in Schistosoma haematobium- and S. mansoni-endemic areas [2–4] many
people are at risk of co-infection. Yet, little is known about mixed
Schistosoma infections and their impact on host morbidity.
Clinical manifestations of schistosomiasis are associated with the
species-specific oviposition sites [2]. Both S. haematobium and S.
mansoni mature in the portal vein of the human host and form male-
female pairs. Subsequently, the S. mansoni male carries the female to
the mesenteric plexus whereas the S. haematobium couple continues
its way to the veins of the pelvis. In these respective sites, they lay
eggs, which are eventually eliminated from the body via the urine (S.
haematobium) or feces (S. mansoni). About half of the eggs, however, are
carried away with the blood stream and/or trapped in the tissues.
These retained eggs provoke inflammatory and granulomatous
immune responses [2]. For S. haematobium, this can lead to
inflammation, ulceration and pseudopolyposis of bladder and
ureteral walls, and in children this is often accompanied by
hematuria. Chronic lesions may evolve to fibrotic and sandy patches
with severe sequelae such as hydroureter, hydronephrosis, and
squamous bladder cancer [2,5,6]. For S. mansoni, egg deposition can
lead to inflammatory hepatic schistosomiasis and hepatospleno-
megaly in children and adolescents [7]. Trapped schistosomal eggs
are gradually replaced by fibrotic deposits, and give rise to chronic
hepatic schistosomiasis [2].
In mixed S. mansoni and S. haematobium infections, the above-
described processes act in parallel, which may result in more
severe or other abnormalities than in single infections. So far, only
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two studies have investigated the relationship between mixed
infections and host morbidity. In Zimbabwe, a positive association
between S. mansoni egg output and liver size was found in the
presence but not in the absence of S. haematobium. Yet, this effect
was very little [8]. In a study in Mali, mixed infection was
associated with reduced hepatic morbidity on one hand and
increased bladder morbidity on the other [9]. Both studies were
performed in schoolchildren, in whom severe hepatic schistoso-
miasis is unlikely to have developed already [2,7,10]. Community-
wide studies would therefore be more appropriate to investigate
mixed infections and morbidity.
In northern Senegal, many communities have in the past
decades become co-endemic for S. mansoni and S. haematobium [11–
16]. Schistosoma mansoni was introduced in Richard-Toll in 1988
upon construction of the Diama dam and rapidly spread
throughout the region [17,18]. By 1994, virtually the entire
Guiers Lake (‘Lac de Guiers’) area had become exposed to this
species [19]. Today, both S. mansoni and S. haematobium are widely
spread, resulting in a large number of people with mixed infections
in the communities around the lake.
Recently, we reported on the distribution of and risk factors for
mixed Schistosoma infections in two communities on the banks of
Lake Guiers. Individuals with mixed infections were found to have
higher infection intensities than those with single infections [20].
In the present study, we set out to investigate the relationship
between mixed Schistosoma infections and morbidity in the same
communities. We studied the patterns of S. haematobium-specific
bladder morbidity and S. mansoni-specific hepatic morbidity in this
co-endemic focus, and compared morbidity in people with mixed
Schistosoma infections to those with single infections.
Methods
Ethics Statement
This study was part of a larger investigation on the epidemi-
ology of schistosomiasis and innate immune responses (SCHIS-
TOINIR: www.york.ac.uk/res/schistoinir) for which approval was
obtained from the review board of the Institute of Tropical
Medicine, the ethical committee of the Antwerp University
Hospital and ‘Le Comite´ National d’Ethique de la Recherche en
Sante´’ in Dakar. Informed and written consent was obtained from
all participants prior to inclusion into the study.
Study Area
This study was conducted from July until November 2009 in
Ndieumeul (also known as Thieke`ne) and Diokhor Tack, two
neighboring communities on the Nouk Pomo peninsula in Lake
Guiers. Details on the study area have been described elsewhere
[20].
Parasitology and Urine Dipstick
Two urine and two feces samples were collected from each
participant on consecutive days for microscopic analysis [21,22].
Per feces sample, two Kato-Katz slides of 25 mg fecal material
each were prepared and microscopically examined for Schistosoma
species [22]. Schistosoma mansoni infection intensity was expressed as
the number of eggs detected per gram of feces (epg). Urine
filtration was performed using a filter of 12 mm pore-size (Isopore)
according to standard procedures [21]. Schistosoma haematobium
infection intensity was expressed as the number of eggs detected
per 10 ml of urine (ep10ml). Ectopic eggs were measured
qualitatively (positive/negative). Ectopic egg elimination refers to
elimination of schistosomal eggs via the unusual route – i.e. S.
mansoni eggs in urine or S. haematobium eggs in feces. Single infection
was defined as passing eggs of only one species, and mixed
infection as passing eggs of both S. mansoni and S. haematobium,
regardless of the route of egg elimination [20]. Microhematuria
was determined in a subsample using Combur 7 dipsticks (Roche)
on the first urine sample. All community members were offered
praziquantel (one dose of 40 mg/kg body weight) and mebenda-
zole (one dose of 500 mg) treatment after the study according to
WHO guidelines [23].
Ultrasound
Participants were examined using a portable ultrasonography
device with convex transducer. Pathologic lesions associated with
S. haematobium or S. mansoni infection were recorded according to
the Niamey guidelines [10]. All examinations were performed by
the same clinician who was blind to the participant’s infection
status. Participants with severe pathology that needed further
treatment were referred to the appropriate health authority. For S.
haematobium-specific morbidity, the urinary bladder score was
determined [10]. A score of $1 was considered as S. haematobium-
specific urinary bladder morbidity in accordance with previous
studies [9,24–30]. Individuals with a score of 0 were categorized as
controls. For S. mansoni-specific morbidity, the liver image pattern
was determined [10]. Additional measurement of periportal
thickening was not included as this approach has been shown to
be not reproducible [31]. Liver image patterns of C to F were
categorized as S. mansoni-specific hepatic morbidity [31–35].
Individuals with liver image pattern A or B are not likely to have
periportal fibrosis [10] and were therefore categorized as controls.
Individuals with signs of hepatic morbidity that were not specific
for S. mansoni (e.g. hepatitis, cirrhosis or fatty liver) were excluded
[10].
Statistical Analysis
IBM SPSS 19.0 (SPSS, Inc.) was used for statistical analysis.
Results were considered significant when the p-value was ,0.05.
As egg outputs showed skewed distributions, data were normalized
Author Summary
In the developing world, over 207 million people are
infected with parasitic Schistosoma worms. Schistosoma
haematobium and S. mansoni are the most abundant
species in Africa and many people carry both. Yet, little is
known about the consequences of such mixed infections.
In general, S. haematobium affects the urinary tract of the
host and S. mansoni the liver. Here, we investigated the
effect of mixed Schistosoma infection on these health
problems. We examined 403 people from northern
Senegal for Schistosoma infections as well as for abnor-
malities of the urinary bladder and liver. Recently, we
observed that people with mixed Schistosoma infections
had generally higher infection intensities than those with
single infections. The present study showed that abnor-
malities of the urinary bladder were more common in
heavy than in light S. haematobium infections. Also, they
were more common in single S. haematobium than in
mixed infections. So far, only two studies have looked into
the relationship between mixed Schistosoma infection and
abnormalities of the bladder and liver, but only investi-
gated children. Our findings suggest a possible protective
effect of S. mansoni on bladder disease, in children as well
as in adults. This may have important consequences for
schistosomiasis control in co-endemic areas.
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by log (base 10)-transformation after adding half of the detection
limit to allow for zeros.
Differences between groups were determined by the Pearson Chi-
square test for community and gender, and by the Mann-Whitney
U test for age. Furthermore, the Pearson Chi-square test was used to
determine the association between bladder morbidity and micro-
hematuria, as well as between bladder and liver morbidity.
Because of the non-linear trend of morbidity over age, the
population was divided into four age groups (0–9, 10–19, 20–39
and $40 years) for multivariable regression analysis. Multivariable
logistic regression models were used to identify independent risk
factors for S. haematobium-specific bladder morbidity and S. mansoni-
specific hepatic fibrosis, respectively. Age, gender, community of
residence, S. haematobium infection intensity and S. mansoni infection
intensity were included as potential risk factors. Moreover,
significant interaction terms with age (p,0.05) were added.
Similar models were used to assess the independent effect of
mixed infection (as compared to single infection) on S. haematobium-
specific bladder morbidity and S. mansoni-specific hepatic fibrosis,
respectively. Among S. haematobium-positive subjects, the associa-
tion between bladder morbidity and mixed infection was
investigated using a dummy variable for mixed infection
(1 =mixed, 0 = single), and age, gender, community of residence
and S. haematobium infection intensity as other determinants.
Likewise, the association between hepatic fibrosis and mixed
infection was investigated in S. mansoni-positive subjects with a
dummy variable for mixed infection and upon correction for age,
gender, community of residence and S. mansoni infection intensity.
Results
Complete parasitological data were obtained from 857 individ-
uals [20]. Ultrasound data were collected from a random
subsample of 403 individuals. The latter group consisted of 207
males and 196 females with a median age of 16 (range 3–85) years.
There were no significant dissimilarities between those who
participated in the ultrasound examination and those who did
not, except for a slightly lower percentage of individuals
participating from the community of Ndieumeul as compared to
Diokhor Tack (p=0.005), and from the youngest as compared to
the older age groups (p=0.030). No significant differences in age
or gender were observed between the two communities.
Morbidity Prevalences
Schistosoma haematobium-specific bladder morbidity was observed
in 83% of the study population (334/403; Table 1). Most common
lesions concerned multifocal or diffuse bladder wall thickening
(n= 189), irregularities (n = 94) or a single mass (n = 19). Micro-
hematuria was twice as prevalent among those with bladder
morbidity as compared to those without (44% versus 21%,
p=0.002).
S. mansoni-specific fibrosis was present in 27% (109/403) of the
population (Table 2). Liver image patterns up to F were observed,
but the large majority had pattern C (89/109).
Morbidity of both liver and bladder was observed in 24% (93/
391) of the study participants (Table 3). Those who had bladder
morbidity tended to be more at risk for hepatic fibrosis and vice
versa (odds ratio (OR) = 1.3 (95% confidence interval (CI) 0.7–2.4)).
Age-Related Patterns
Figure 1 shows that bladder morbidity was mainly observed in
children (,20 years), with a peak in 10-to-19-year-olds. The age-
related distribution of bladder morbidity coincided with that of S.
haematobium infection intensity and microhematuria, although the
peak was slightly later in adolescence, and the subsequent decline
in adults less pronounced.
Table 1. Schistosoma haematobium-associated bladder morbidity, hematuria and S. haematobium infection in the two co-endemic
communities studied.
Morbidity Urinary bladder score n (%) Microhematuria (%) S. haematobium infection
% GM (95%CI)a
Negative 0 69 (17) 21 33 3.9 (1.8–8.1) ep10ml
Positive $1 334 (83) 44 58 8.8 (6.7–11.5) ep10ml
1 15 (4) 62 73 8.5 (2.2–31.5) ep10ml
2 301 (75) 42 56 8.5 (6.4–11.3) ep10ml
$3 18 (4) 71 78 13.1 (4.2–39.5) ep10ml
Total 403 (100) 40 54 8.1 (6.2–10.4) ep10ml
aGM) Geometric Mean; calculated for microscopically S. haematobium-positive individuals only.
doi:10.1371/journal.pntd.0001829.t001
Table 2. Schistosoma mansoni-associated hepatic fibrosis and
S. mansoni infection in the two co-endemic communities
studied.
Morbidity
Liver image
pattern n (%) S. mansoni infection
% GM (95%CI)a
Negative A–B 282 (70) 72 123 (99–153) epg
A 142 (35) 75 131 (98–175) epg
B 140 (35) 69 115 (83–160) epg
Positive C–F 109 (27) 61 113 (76–168) epg
C 89 (22) 63 125 (81–193) epg
D 10 (2) 40 113 (29–400) epg
E 9 (2) 67 45 (10–160) epg
F 1 (0.2) 0 N/A
Excluded 12 (3)
Total 403 (100) 69 120 (99–145) epg
aGM) Geometric Mean; calculated for microscopically S. mansoni-positive
individuals only. N/A) Not Applicable.
doi:10.1371/journal.pntd.0001829.t002
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The prevalence of hepatic fibrosis increased from 6% in 0-to-9-
year-olds to 44% in those$20 years old. The more severe forms of
hepatic fibrosis (liver image patterns D, E and F) only became
apparent in adults ($20 years old). The peak in the age-related
distribution of hepatic fibrosis occurred more than 10 years later in
life than the S. mansoni infection intensity peak (Figure 1).
Risk Factors
Multivariable analysis showed age to be a significant risk factor for
bladder morbidity as well as hepatic fibrosis (Table 4). However, age-
related patterns of hepatic fibrosis differed between the two
communities (p=0.033): while the ORs for hepatic fibrosis increased
with age in Diokhor Tack (p,0.001), they did not vary with age in
Ndieumeul (data not shown). Individuals from Diokhor Tack were
significantly more at risk for hepatic fibrosis but tended to be less at
risk for bladder morbidity than their counterparts from Ndieumeul
(Table 4). Furthermore, females were less at risk for both forms of
morbidity than males. Neither S. mansoni intensity nor S. haematobium
intensity was identified as an independent risk factor for hepatic
fibrosis. On the other hand, S. haematobium (but not S. mansoni)
infection intensity was a strong risk factor for bladder morbidity.
Effect of Mixed Infection
After including mixed infection into the multivariable model,
the above-described trends remained the same (Table 5). The risk
of hepatic fibrosis did not differ between subjects with single S.
mansoni and those with mixed infections. Interestingly however,
mixed infection tended to be negatively associated with S.
haematobium-specific bladder morbidity, suggesting a protective
effect of current S. mansoni infection (p=0.068).
Ectopic Egg Elimination and Bladder Morbidity
Ectopic S. haematobium eggs were found in one (0.6%) and ectopic S.
mansoni eggs in 23 (13%) out of 176 individuals with mixed infections.
Table 6 illustrates the importance of the route of S. mansoni egg
elimination in the development of bladder morbidity. Those who
eliminated S. mansoni via both urine and feces (n=17) had highest S.
haematobium infection intensities and prevalences of bladder morbidity.
Lowest prevalences of morbidity were observed in those who
exclusively eliminated S. mansoni eggs via the urine (and not via the
feces; n=6), despite relatively high S. haematobium infection intensities.
Discussion
The global distribution map of schistosomiasis shows a large
overlap of Schistosoma mansoni- and S. haematobium-endemic areas in
Africa [2–4]. Yet, little is known about the consequences of mixed
Schistosoma infections for the human host. Here, we report on the
relationship of mixed Schistosoma infections with S. haematobium-
specific bladder morbidity and S. mansoni-specific hepatic morbid-
ity in two co-endemic communities.
Risk factors for schistosomal morbidity in this co-endemic area –
i.e. age, gender, community of residence – were similar to those
generally observed in Schistosoma-endemic areas. In line with other
studies in mono-endemic areas, we observed that children are more
at risk of bladder morbidity [36,37], while adults are more at risk for
hepatic fibrosis [2,38]. Participants from one community tended to
be less at risk for bladder morbidity but were significantly more at
risk for hepatic fibrosis than participants from the other. Micro-
geographical differences (i.e. between neighboring communities)
have been reported before [32–34,39], and are probably due to
geographical heterogeneities in Schistosoma exposure (history) [20,40–
42], although other factors (e.g. genetic or environmental factors)
may also be involved [39]. Males were more at risk for bladder
morbidity and hepatic fibrosis than females. Previous studies in either S.
mansoni- or S. haematobium-endemic areas have found similar associations
for both forms of morbidity [25,30–34,36,38,43–49]. Possibly, males
Figure 1. Age distribution of schistosomiasis morbidity in the two co-endemic communities studied. Colored stacks indicate morbidity
prevalences and continuous black lines indicate mean 10log-transformed infection intensities among positive subjects with the standard error of the
mean (whiskers). Panel A: Different forms of S. haematobium-specific bladder morbidity are denoted by a color gradient: light yellow stacks
designate a urinary bladder score of 1, bright yellow a score of 2 and orange (3 and 4), red (5) and violet (6) indicate higher morbidity scores. The
dotted red line indicates hematuria prevalence in a subsample (n = 317). Panel B: The severity of S. mansoni-specific fibrosis is denoted by a color
gradient. Yellow stacks designate liver image pattern C, orange pattern D, red pattern E, and violet stacks indicate pattern F. Striped stacks designate
those with borderline liver morbidity (pattern B, not classified as morbidity).
doi:10.1371/journal.pntd.0001829.g001
Table 3. Bladder and liver co-morbidity in the two co-
endemic communities studied.
Bladder morbidity Hepatic fibrosis
Negative Positive Total
Negative 51 16 67
Positive 231 93 324
Total 282 109 391
Number of cases.
doi:10.1371/journal.pntd.0001829.t003
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are more prone to Schistosoma-associated pathology because of
hormonal and immunological differences. It has been proposed that
hepatic fibrosis might be more pronounced in men because androgens
can reduce interferon (IFN)-c levels while estrogens have the opposite
effect on this antifibrogenic cytokine [43]. Similarly, a study in Uganda
showed that the risk of hepatic fibrosis was associated with different
cytokine profiles in men and women [35].
Recently, we found infection intensities of both S. mansoni and S.
haematobium to be elevated in mixed as compared to single infections
[20]. In the present study, S. haematobium infection intensity was
identified as an independent risk factor for bladder morbidity, in
accordance with previous studies from mono-endemic areas
[29,30,36,44–48,50]. However, subjects with mixed infections
tended to have less bladder morbidity than those with single S.
Table 4. Risk factors for schistosomiasis morbidity in the total study population.
Risk factors S. haematobium-specific bladder morbidity (n=403) S. mansoni-specific hepatic fibrosis (n =391)
n
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI) n
Unadjusted OR
(95%CI)
Adjusted OR
(95%CI)
Agea ,10 y 102 0.3 (0.1–0.7)** 0.3 (0.1–0.8)* 102 0.1 (0.03–0.2)*** 0.1 (0.01–1.3)
10–19 y 121 Ref. Ref. 119 0.4 (0.2–0.7)** 1.4 (0.4–5.1)
20–39 y 109 0.3 (0.1–0.7)** 0.6 (0.3–1.3) 105 Ref. Ref.
$40 y 71 0.4 (0.2–0.97)* 0.9 (0.3–2.3) 65 1.0 (0.6–1.9) 0.7 (0.1–3.8)
Gender Male 207 Ref. Ref. 200 Ref. Ref.
Female 196 0.4 (0.2–0.7)*** 0.3 (0.2–0.6)*** 191 0.8 (0.5–1.3) 0.5 (0.3–0.9)*
Community Ndieumeul 100 Ref. Ref. 99 Ref. Ref.
Diokhor Tack 303 0.4 (0.2–0.8)* 0.6 (0.3–1.3) 292 1.9 (1.1–3.3)* 5.1 (1.3–20.8)*
S. haematobium Infection intensityb 403 2.0 (1.4–2.9)*** 1.9 (1.3–2.9)** 391 0.6 (0.5–0.8)*** 0.9 (0.7–1.3)
S. mansoni Infection intensityb 403 1.5 (1.1–2.1)* 1.1 (0.8–1.6) 391 0.8 (0.6–1.0) 0.9 (0.6–1.3)
Interaction Age6community N/A N/A N/A 391 N/A p=0.033a
OR) Odds Ratio; 95%CI) 95% Confidence Interval; Ref.) Reference category; N/A) Not Applicable; *) p,0.05; **) p,0.01; ***) p,0.001.
aFor S. haematobium-specific bladder morbidity, the trend with age was significant at the level of p= 0.025 in the uni- and p=0.043 in the multivariable analysis. For S.
mansoni-specific hepatic fibrosis, the trend with age was significant in the crude analysis (p,0.001). In the adjusted analysis the ORs for hepatic fibrosis increased with
age in Diokhor Tack (p,0.001) but they did not vary with age in Ndieumeul.
bOR for a 10-fold increase in infection intensity.
doi:10.1371/journal.pntd.0001829.t004
Table 5. The effect of mixed Schistosoma infection on bladder morbidity and on hepatic fibrosis.
Risk factors
Bladder morbidity in S. haematobium-infected
subjects (n =216)
Hepatic fibrosis in S. mansoni-infected subjects
(n=270)
n
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI) n
Unadjusted OR
(95%CI)
Adjusted OR
(95%CI)
Agea ,10 y 63 0.3 (0.1–1.1) 0.2 (0.1–0.9)* 65 0.1 (0.03–0.3)*** 0.1 (0.02–0.2)***
10–19 y 88 Ref. Ref. 102 0.4 (0.2–0.8)** 0.3 (0.2–0.7)**
20–39 y 44 0.2 (0.1–0.8)* 0.3 (0.1–1.2) 66 Ref. Ref.
$40 y 21 0.3 (0.1–1.4) 0.5 (0.1–3.0) 37 0.8 (0.3–1.8) 0.8 (0.4–1.9)
Gender Male 109 Ref. Ref. 140 Ref. Ref.
Female 107 0.3 (0.1–0.8)* 0.3 (0.1–0.9)* 130 1.0 (0.6–1.8) 0.6 (0.3–1.2)
Community Ndieumeul 70 Ref. Ref. 87 Ref. Ref.
Diokhor Tack 146 0.2 (0.04–0.8)* 0.2 (0.04–0.7)* 183 1.5 (0.8–2.8) 1.6 (0.8–3.2)
S. haematobium Infection intensityb 216 1.8 (0.96–3.3) 1.8 (0.9–3.7) N/A N/A
S. mansoni Infection intensityb N/A N/A 270 0.9 (0.6–1.4) 1.0 (0.7–1.7)
Mixed infection No 40 Ref.c Ref.c 97 Ref.d Ref.d
Yes 176 0.6 (0.2–2.2) 0.3 (0.1–1.1) 173 0.8 (0.6–1.1) 1.1 (0.8–1.5)
OR) Odds Ratio; 95%CI) 95% Confidence Interval; Ref.) Reference category; N/A) Not Applicable; *) p,0.05; **) p,0.01; ***) p,0.001.
aThe trends with age were not significant for S. haematobium-specific bladder morbidity, but for S. mansoni-specific hepatic fibrosis, they were at the level of p,0.001 in
both analyses.
bOR for a 10-fold increase in infection intensity.
cMixed infections as compared to single S. haematobium infections.
dMixed infections as compared to single S. mansoni infections.
doi:10.1371/journal.pntd.0001829.t005
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haematobium infections, independently of infection intensity. This
would suggest a protective effect of S. mansoni on bladder morbidity.
The observed reduction in bladder morbidity in mixed
infections appeared to be related to ectopic S. mansoni egg
elimination. Lowest prevalences of bladder morbidity were
observed in S. haematobium-positive individuals who also eliminated
S. mansoni eggs in urine (but not in feces), despite the relatively high
S. haematobium infection intensities in this group. Experimental
models have shown that S. mansoni and S. haematobium can form
heterologous male-female pairs. As the S. haematobium male is
assumed to be competitively stronger than S. mansoni [51,52], this
would result in more heterologous pairs in the vesical than in the
mesenteric plexus and thus in more ectopic S. mansoni than ectopic
S. haematobium egg elimination in mixed foci [12,20,51–55].
Nothing is known yet about the pathogenicity of eggs from
heterologous pairs [54,56]. It could be speculated however, that
these heterologous pairs would produce less (pathogenic) eggs than
homologous S. haematobium worm pairs, or that their eggs would
deviate to other sites [57,58]. Competition between S. mansoni and
S. haematobium females for S. haematobium males would then lead to a
reduction of bladder morbidity in mixed as opposed to single
infections. Other factors may also underlie the potential protective
effect of S. mansoni infection. As our study population has been
exposed to S. mansoni for a longer period of time than to S.
haematobium [19], one could argue that S. mansoni-induced cross-
resistance to S. haematobium might have played a role as well [59].
Obviously, more research is needed to confirm the observed
relation between mixed Schistosoma infection and bladder morbid-
ity, and to understand the underlying mechanisms.
Only one epidemiological study has looked into mixed infections
and bladder morbidity before. In contrast to our study, the authors
reported a positive association between mixed infection and bladder
morbidity in Malian subjects [9]. However, they studied only
schoolchildren (7–14 years) and did not take ectopic egg elimination
into account. Restricting our analysis to children between 5 and 14
years (the limited sample size did not allow us to perform the analysis
on a smaller age range), the association between mixed infection and
bladder morbidity still tended to be negative (OR=0.5 (95%CI 0.1–
3.4)). Disregarding ectopic eggs as well, the association became positive
(OR=1.7 (95%CI 0.4–7.6)), which is in line with the Malian study
(data not shown). These discrepancies clearly demonstrate the
importance of considering ectopic egg elimination in mixed Schistosoma
infections and morbidity.
In contrast to our findings for bladder morbidity, hepatic fibrosis
was neither associated with current S. mansoni infection intensity nor
with mixed infections. Hepatic fibrosis only develops after 5–15 years
of exposure to S. mansoni [2]. This was illustrated by the .10 years’
time lag between the S. mansoni infection and S. mansoni-associated
hepatic fibrosis peaks in the respective age-related curves (Figure 1).
While inflammatory hepatic morbidity is generally positively
associated with current S. mansoni infection [2,60,61], the progression
of morbidity into chronic schistosomiasis is driven by cumulative
exposure to S. mansoni eggs rather than current infection [7,62,63].
So far, only two other studies have investigated the relationship
between mixed infections and liver morbidity, with contrasting results.
A Zimbabwean study found a slight positive association betweenmixed
infections and liver size [8]. The afore-mentioned Malian study
observed a negative association between mixed infections and hepatic
fibrosis [9]. However, the latter classified liver image pattern B as
abnormal [24], which is not according to the Niamey guidelines
[10,31–35], and hampers an adequate comparison with our findings.
Adopting the criteria of the Malian study, we still found a positive
association betweenmixed infections and liver fibrosis in children (7–14
years), although not significant (data not shown). The divergences
between the Malian study and our study – for bladder as well as liver
morbidity – could furthermore be due to differences in the distribution
of S. haematobium and S. mansoni infection status and intensity between
the three Malian study areas, which were not accounted for [9]. Also
other differences in e.g. transmission dynamics [39], between the
Malian and present study cannot be excluded.
Conclusion
Up to now, the relationship between mixed Schistosoma infection and
morbidity has only been studied in schoolchildren. This population-
wide study is the first to include adults. Mixed infections were not
associated with an increased risk of S. mansoni-associated morbidity and
even tended to reduce the risk of bladder morbidity. These unexpected
results warrant further investigation of a possible protective effect of S.
mansoni on bladder morbidity. Especially the role of interspecies
interactions and ectopic S. mansoni egg elimination should be studied in
more detail, as these phenomena may have important consequences
for schistosomiasis morbidity and control in co-endemic areas.
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Table 6. S. mansoni egg elimination, infection intensity and bladder morbidity in subjects passing S. haematobium eggs in urine.
Route of S. mansoni egg elimination n
S. haematobium infection intensity
(GM (95% CI))a Bladder morbidity (%)
No elimination (single S. haematobium infection) 39 3.1 (2.0–4.7) ep10ml 92
Exclusively via feces (mixed infection) 153 8.0 (6.0–10.8) ep10ml 89
Via feces & urine (mixed infection) 17 60.1 (27.2–132.3) ep10ml 100
Exclusively via urine (mixed infection) 6 12.0 (1.5–86.5) ep10ml 50
Total 215 8.1 (6.2–10.4) ep10ml 89
aGM) Geometric Mean; 95%CI) 95% Confidence Interval.
doi:10.1371/journal.pntd.0001829.t006
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